Genetics of obesity and obesity-related hypertension

被引:9
|
作者
Hamann, A
Sharma, AM
机构
[1] Univ Heidelberg, Dept Internal Med, D-6900 Heidelberg, Germany
[2] Humboldt Univ, Franz Volhard Clin, Charite, D-1086 Berlin, Germany
[3] Max Delbruck Ctr Mol Med, Berlin, Germany
关键词
D O I
10.1053/snep.2002.30208
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Obesity results from an imbalance between caloric intake and energy expenditure. Twin, adoption, and family studies have not only shown that genetic factors play an important role in the pathogenesis of obesity, but also contribute to several comorbidities including hypertension and type 2 diabetes. In recent years, several single-gene defects responsible for obesity in rodents and, in rare cases, of human obesity have been identified. Besides leptin as the most notable example, numerous other proteins and neuropeptides have recently been found that participate in a complex network to regulate food intake and energy expenditure. Interestingly, some of these molecules may also play a role in the development of obesity-related hypertension. The ongoing search for relevant genetic variants should result in a better understanding of energy metabolism and hopefully clarify molecular mechanisms underlying the association between obesity and related comorbidities. This knowledge should help develop new strategies for the treatment of obesity and associated risk factors for hypertension and related cardiovascular disorders.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 50 条
  • [21] The Role of Aldosterone in Obesity-Related Hypertension
    Kawarazaki, Wakako
    Fujita, Toshiro
    AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (04) : 415 - 423
  • [22] Role of leptin in obesity-related hypertension
    Haynes, WG
    EXPERIMENTAL PHYSIOLOGY, 2005, 90 (05) : 683 - 688
  • [23] Treatment strategies for obesity-related hypertension
    Efrain Reisin
    Current Hypertension Reports, 2008, 10 : 129 - 130
  • [24] Uric acid level is one of the predictors of hypertension, obesity and obesity-related hypertension
    Masuo, K
    Mikami, H
    Ogihara, T
    Tuck, ML
    HYPERTENSION, 2002, 40 (03) : 385 - 385
  • [25] Neural mechanisms in human obesity-related hypertension
    Rumantir, MS
    Vaz, M
    Jennings, GL
    Collier, G
    Kaye, DM
    Seals, DR
    Wiesner, GH
    Brunner-La Rocca, HP
    Esler, MD
    JOURNAL OF HYPERTENSION, 1999, 17 (08) : 1125 - 1133
  • [26] Obesity-related hypertension: possible pathophysiological mechanisms
    Vaneckova, Ivana
    Maletinska, Lenka
    Behuliak, Michal
    Nagelova, Veronika
    Zicha, Josef
    Kunes, Jaroslav
    JOURNAL OF ENDOCRINOLOGY, 2014, 223 (03) : R63 - R78
  • [27] Adrenergic and reflex abnormalities in obesity-related hypertension
    Grassi, G
    Seravalle, G
    Dell'Oro, R
    Turri, C
    Bolla, GB
    Mancia, G
    HYPERTENSION, 2000, 36 (04) : 538 - 542
  • [28] Hydralazine as antihypertensive therapy in obesity-related hypertension
    Carroll, JF
    King, JW
    Cohen, JS
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (03) : 384 - 390
  • [29] Increased circulating endothelin-1 in obesity-related hypertension, but not in obesity or hypertension alone
    Lilyasan, Oktavia
    Kosasih, Adrianus
    Liasturti, Lies D.
    Librantoro
    Gunawan, I. R.
    Idham, Idris
    Raharjo, Sunu B.
    Harimurti, Ganesja M.
    CIRCULATION, 2007, 116 (16) : 341 - 341
  • [30] Treatment of Obesity-Related Hypertension in Children and Adolescents
    Halbach, Susan M.
    Flynn, Joseph
    CURRENT HYPERTENSION REPORTS, 2013, 15 (03) : 224 - 231